Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV005379239 | SCV006041490 | uncertain significance | not specified | 2024-12-11 | criteria provided, single submitter | clinical testing | The c.1519C>A (p.Q507K) alteration is located in exon 2 (coding exon 2) of the NPC1L1 gene. This alteration results from a C to A substitution at nucleotide position 1519, causing the glutamine (Q) at amino acid position 507 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |